Quantifying Neutralizing Antibodies in Patients with COVID-19 by a Two-Variable Generalized Additive Model
2변수 일반화 첨가제 모델을 통한 COVID-19 환자의 중화 항체 정량화
Research Article
[키워드] “COVID-19
acute respiratory syndrome
Additive
Additive Model
analyzed
antibodies
antibody
Antibody binding
Antibody titer
Antibody titers
approach
binding
binding affinity
Biology
biosafety
biosafety level
certification
Clinical use
Combination
conventional virus neutralization test
coronavirus
correlation
CoV
COVID-19
detect
disease
domain
Efficacy
ELISA
enzyme
enzyme-linked immunosorbent
enzyme-linked immunosorbent assay
faster
Generalized
gold
gold standard
healthy donors
Immunity
Laboratory
level 2
mathematics
methodology
Model
neutralization test
Neutralizing antibodies
neutralizing antibody
Neutralizing antibody titer
neutralizing antibody titers
Patient
patients with COVID-19
PCR-confirmed
Perspective
platform
predicted
RBD
Receptor-binding domain
reflected
regions
risk
SARS-CoV-2
SARS-CoV-2 antibodies
SARS-CoV-2 antibody
SARS-COV-2 infection
SARS-CoV-2 infections
SARS-CoV-2 viral
Serological testing
serum
Severe acute respiratory syndrome
Severe Acute Respiratory Syndrome CoV
specimens
Spike protein
surrogate
the binding affinity
the RBD
time-consuming
Travel
two-variable generalized additive model
Vaccine
vaccine efficacy
Viral
viral spike protein
virus neutralization test
with COVID-19
[DOI] 10.1128/msphere.00883-21 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1128/msphere.00883-21 PMC 바로가기 [Article Type] Research Article